Pharmaceutical CAS 58186 -27-9 Antioxidant Idebenone Nootropics Idebenone Powder Idebenone

China Pharmaceutical CAS 58186-27-9 Antioxidant Idebenone Nootropics Idebenone Powder Idebenone, Find details about China Idebenone, Idebenone Powder from Pharmaceutical CAS 58186-27-9 Antioxidant Idebenone Nootropics Idebenone Powder Idebenone

Basic Info.

Model NO.

D-sung Idebenone

Product Name

Idebenone

Name

Idebenone Powder

Appearance

Orange Yellow Powder

Color

Orange Yellow

Store

Cool and Dry

Grade

Pharmaceutical Grade

Assay

HPLC 99%

Application

Anthelmintics

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

CAS No.

58186-27-9

Molecular Formual

C19h30o5

Density

1.1 g/cm3

Melting Point

52-55 C

Trademark

D-Sung

Transport Package

Negotiable

Specification

99%

Origin

Xi′an Shaanxi

Model NO.

D-sung Idebenone

Product Name

Idebenone

Name

Idebenone Powder

Appearance

Orange Yellow Powder

Color

Orange Yellow

Store

Cool and Dry

Grade

Pharmaceutical Grade

Assay

HPLC 99%

Application

Anthelmintics

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

CAS No.

58186-27-9

Molecular Formual

C19h30o5

Density

1.1 g/cm3

Melting Point

52-55 C

Trademark

D-Sung

Transport Package

Negotiable

Specification

99%

Origin

Xi′an Shaanxi

Product Desciption

Pharmaceutical CAS 58186-27-9 Antioxidant Idebenone Nootropics Idebenone Powder Idebenone

Product name	Idebenone
Appearance	Orange Yellow powder
CAS	58186-27-9
MF	C19H30O5

Idebenone (trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013[update] the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe. Chemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10).

Damage to brain function caused by chronic cerebrovascular disease and brain trauma caused by idbenzoquinone. can improve subjective symptoms, language, anxiety, depression, memory loss, intelligence decline and other mental behavior disorders.
1.Idebenone increases nerve growth factor (NGF) in the brain.
2.Idebenone is a powerful antioxidant and positively affects brain chemistry.
3.Idebenone has been shown to promote information transfer across the corpus callosum, the membrane separating the right and left brain hemispheres.
4. Idebenone has been used to treat Alzheimer's and to lessen damage from strokes.
5. Idebenone can increase production of the brain neurotransmitters serotonin, dopamine, adrenalin, and noradrenanlin.